Journals / Turkish Journal of Pediatrics / 2021 / Cilt: 63 - Sayı: 2

Upward trend in the frequency of community-acquired methicillin-resistant Staphylococcus aureus as a cause of pediatric skin and soft tissue infections over five years: a cross-sectional study

Pages
200–205
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The clinical impact of this increase should be evaluated, especially in patients with SSTI who are unresponsive to empirical treatment

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) and its resistance to multiple antibiotics has become a serious challenge since the early 2000s.
📊
Key Findings & Data:Especially, community-acquired MRSA (CA-MRSA) infections that appear mainly as skin and soft tissue infections (SSTIs) tend to increase worldwide.
💡
Conclusion & Impact:The clinical impact of this increase should be evaluated, especially in patients with SSTI who are unresponsive to empirical treatment
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Özet

Background. The increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) and its resistance to multiple antibiotics has become a serious challenge since the early 2000s. Especially, community-acquired MRSA (CA-MRSA) infections that appear mainly as skin and soft tissue infections (SSTIs) tend to increase worldwide. The objective of this cross-sectional study was to evaluate the trends in the frequency of SSTIs due to community-acquired S. aureus among children. Methods. All children with SSTIs caused by culture positive community-acquired S. aureus during the period from 2013 to 2018 were included in this study. Data of the outpatients were collected from medical records. Annual alteration in frequencies of CA-MRSA and community-acquired methicillin-sensitive S. aureus (CA- MSSA) were evaluated. Results. A total of 112 cases was evaluated. Of these, 35 (31.25%) were CA-MRSA. The rates of CA-MRSA had emerged from an increasing annual frequency of 9.5 cases per 10,000 SSTIs as of 2014 to 96.8 cases per 10,000 SSTIs in 2018. The ratio of cases with CA-MRSA to cases with CA-MSSA was 0 – 0.09 in two years of the study period and increased to a maximum ratio of 0.6 – 0.72 in the last two years. Consequently, the frequency of S. aureus in cases with SSTIs was significantly higher in 2016 – 2018 compared to the initial study period within the years of 2013-2015 [p<0.001, relative risk increase: 7 (2.6-28.7) for CA-MRSA and p=0.002, relative risk increase: 2.1 (1.2-3.5)]. Cases with CA-MRSA increased approximately eight-fold during the six-year-study period. Conclusions. The rates of CA-MRSA in SSTIs among children increased significantly compared to CA-MSSA. The clinical impact of this increase should be evaluated, especially in patients with SSTI who are unresponsive to empirical treatment

🔖

Cite This Article

BÖNCÜOĞLU, E., KIYMET, E., ÇAĞLAR, İ., ORUÇ, Y., DEMİRAY, N., KARA, A. A., ERDEM, T., GÜLFİDAN, G., DEVRİM, İ., BAYRAM, N. (2021). Upward trend in the frequency of community-acquired methicillin-resistant Staphylococcus aureus as a cause of pediatric skin and soft tissue infections over five years: a cross-sectional study. Turkish Journal of Pediatrics, Cilt: 63 - Sayı: 2, 200–205. https://ajindex.com/articles/411951

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Shanson DC. Staphylococcal infections in hospital. Br J Hosp Med 1986; 35: 312-320
  2. Chambers HF. The changing epidemiology of Staphylococcus aureus. Emerg Infect Dis 2001; 7: 178-182
  3. Purcell K, Fergie J. Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: a 14-year study at Driscoll Children’s Hospital. Arch Pediatr Adolesc Med 2005; 159: 980- 985
  4. Fortunov RM, Hulten KG, Hammerman WA, Mason EO Jr, Kaplan SL. Community-acquired Staphylococcus aureus infections in term and near- term previously healthy neonates. Pediatrics 2006; 118: 874-881
  5. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40: 1785-1791
  6. Fortunov RM, Hulten KG, Hammerman WA, Mason EO Jr, Kaplan SL. Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and late-preterm previously healthy neonates. Pediatrics 2007; 120: 937-945
  7. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368: 874- 885
  8. Peltola H, Pääkkönen M, Kallio P, Kallio MJ; Osteomyelitis-Septic Arthritis (OM-SA) Study Group. Prospective, randomized trials of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis. Clin Infect Dis 2009; 48: 1201-1210
  9. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010; 23: 616-687
  10. Maree C, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated methicillin- resistant Staphylococcus aureus isolates and healthcare-associated infections. Emerg Infect Dis 2007; 13: 236-242
  11. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. (28th ed) CLSI Supplement M100 (ISBN 1-56238-838-X [Print]; ISBN 1-56238- 839-8 [Electronic]). Pennsylvania: Clinical and Laboratory Standards Institute, 2018. Available at: http://file.qums.ac.ir/repository/mmrc/CLSI-2018- M100-S28.pdf (Accessed on April 14, 2020)
  12. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Available at: https://pdfs.semanticscholar. org/8fa9/0d4e48d77c9fb0e33a4e700d45cdde09b232.